5 Questions That Put Sponsors Back in Control of Bioanalysis Projects
By Ander Tallett, COO and Co-Founder, Dash Bio
Quality bioanalysis is crucial for program success, yet all CROs claim speed and quality. However, since the bioanalysis market is no longer capacity-constrained, you have leverage to demand better.
Focus on partnerships delivering cutting-edge technology, transparent pricing, real oversight, genuine partnership, and risk protection. Engage a partner 6-12 months before IND submission. Demand accountability, utilizing specific questions to distinguish real capabilities from marketing claims. Five key questions will help you differentiate marketing bravado from legitimate capability.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.